MINOCIN SA Modified release hard capsule Ref.[50816] Active ingredients: Minocycline

Source: Health Products Regulatory Authority (IE)  Revision Year: 2020  Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

5.1. Pharmacodynamic properties

Minocin SA capsules contain the active ingredient minocycline as minocycline hydrochloride, a semi-synthetic derivative of tetracycline.

5.2. Pharmacokinetic properties

Minocin SA capsules have been formulated as a double pulse delivery system in which a portion of the minocycline dose is delivered in the stomach, and a second portion of the dose is available for absorption in the duodenum and upper GI tract.

5.3. Preclinical safety data

None stated.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.